-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Telemedicine: The Pandemic Kicked This Hypergrowth Trend Into Overdrive
Everything points to massive growth in telemedicine in the coming years. And Teladoc stock is one of the biggest players in this trend.
3 Numbers to Study Before Jumping on the Tilray Bandwagon
Before you decide to buy or sell Tilray stock and move on to another cannabis play, at least take the time to consider three numbers from its quarterly report. I won’t say which way I’m leaning toward Tilray until the end -- the last time I wrote about TLRY in November, I cautioned investors to wait for a catalyst before buying -- but I can say that Tilray’s business isn’t nearly as bad as the headlines suggest.
Is It Time to Join the Party and Double Down on Canopy Growth Stock?
If anyone's wondering whether Constellation Brands is confident in its CGC stock holdings, here's your answer.
A Reverse Stock Split Was Too Little, Too Late to Save Aurora Cannabis Stock
With weak fundamentals, and the potential for shares to drop further, sell Aurora stock and consider better pot plays elsewhere.
Is Aurora Stock Worth Owning After Its Reverse Split?
The threat of dilution is real so prospective Aurora stockholders might consider other cannabis-sector investments instead.
Canopy Growth Stock has Upside Potential Emerging From This Covid-19 Hole
At one point pot stocks were all the rage. CGC stock is trying to make a comeback in spite of the drubbing it took during the Covid-19 crash.
Slimmed-Down Canopy Growth Stock Is a Cannabis Winner
Investors are punishing CGC stock for cost-cutting measures, but Canopy Growth now is more likely to survive Covid-19 than its bigger peers.
This Stock Points to the Massive China Biotech Trend
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
Why Investors Should Bet on Canopy Growth Now as it Readies for Later
CGC stock got a lift from production closures worldwide, so as its cost basis shrinks, Canopy Growth will eventually earn profits.
Bullish Play on Inovio as it Develops COVID-19 Vaccine
The major indexes continue to rally. Take advantage by using a bullish position on Inovio Pharmaceuticals, Inc. (NASDAQ:INO).
Technology Stock Profits Will Only Accelerate in the Post-Pandemic World
These must-own investing themes and stocks will continue to pick up steam as the world moves to a new normal after the coronavirus crisis.
Biotech Stocks: Big Buying Opportunities in 2020’s Sector of the Year
Yes, many biotech stocks are down at the moment. But that sets up an incredible chance to get some of the best at a discount.
Best ETFs for 2020: The Alternative Harvest ETF Can Escape Virus Damage
The MJ ETF still has a shot at being one of the best ETFs in 2020, as marijuana becomes an essential business during the coronavirus crisis.
Canopy Growth Stock Is the Best Coronavirus Cannabis Play
Unlike its peers, Canopy Growth has strong fundamentals and an even stronger backer. CGC stock could be a buyout target later this year.
When the Smoke Clears, Canopy Growth Stock Will Be a Winner
Cannabis stocks are getting hammered. But the long-term opportunity remains, and CGC stock will remain the sector's leader.
Canopy Growth Stock: No One is Paying 12 Times Sales for Anything
CGC stock has begun laying off people and closing greenhouses, husbanding cash as the coronavirus ravages the stock of its biggest investor, which makes Corona beer.
Aphria Stock Is a Solid Pick for Speculators Amid Market Turmoil
Along with just about every other cannabis stock, Aphria has been in a tailspin. And the implosion of the overall market has made things even worse. But for investors looking for a speculation, this could be a good one.
